| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blockade of the neurite outgrowth inhibitor Nogo-A in amyotrophic lateral sclerosis
|
Wills, Anne-Marie
|
|
2017
|
16 |
3 |
p. 175-176
2 p.
|
artikel
|
| 2 |
Can natalizumab be beneficial in acute ischaemic stroke?
|
Tatlisumak, Turgut
|
|
2017
|
16 |
3 |
p. 176-177
2 p.
|
artikel
|
| 3 |
Can the optic nerve be repaired?
|
Wilkins, Alastair
|
|
2017
|
16 |
3 |
p. 172-173
2 p.
|
artikel
|
| 4 |
Corrections
|
|
|
2017
|
16 |
3 |
p. 179-
1 p.
|
artikel
|
| 5 |
Dementia research priorities—1
|
Albanese, Emiliano
|
|
2017
|
16 |
3 |
p. 180-181
2 p.
|
artikel
|
| 6 |
Dementia research priorities—2
|
Smith, A David
|
|
2017
|
16 |
3 |
p. 181-182
2 p.
|
artikel
|
| 7 |
Dementia research priorities—2 – Authors' reply
|
Shah, Hiral
|
|
2017
|
16 |
3 |
p. 182-183
2 p.
|
artikel
|
| 8 |
Dementia research priorities—1 – Author's reply
|
Schneider, Lon S
|
|
2017
|
16 |
3 |
p. 181-
1 p.
|
artikel
|
| 9 |
Dementia research priorities—2 – Author's reply
|
Schneider, Lon S
|
|
2017
|
16 |
3 |
p. 182-
1 p.
|
artikel
|
| 10 |
Encephalitis: time to understand
|
Morgan, Jules
|
|
2017
|
16 |
3 |
p. 188-
1 p.
|
artikel
|
| 11 |
Helen Easdale Dimsdale
|
Farrimond, Lucy
|
|
2017
|
16 |
3 |
p. 185-
1 p.
|
artikel
|
| 12 |
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
|
Voon, Valerie
|
|
2017
|
16 |
3 |
p. 238-250
13 p.
|
artikel
|
| 13 |
Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges
|
Fassbender, Klaus
|
|
2017
|
16 |
3 |
p. 227-237
11 p.
|
artikel
|
| 14 |
Rick Bedlack
|
|
|
2017
|
16 |
3 |
p. 186-
1 p.
|
artikel
|
| 15 |
Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
|
Elkins, Jacob
|
|
2017
|
16 |
3 |
p. 217-226
10 p.
|
artikel
|
| 16 |
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
|
Cadavid, Diego
|
|
2017
|
16 |
3 |
p. 189-199
11 p.
|
artikel
|
| 17 |
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
|
Meininger, Vincent
|
|
2017
|
16 |
3 |
p. 208-216
9 p.
|
artikel
|
| 18 |
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
|
Szakacs, Zoltan
|
|
2017
|
16 |
3 |
p. 200-207
8 p.
|
artikel
|
| 19 |
The Babinski sign
|
Drouin, Emmanuel
|
|
2017
|
16 |
3 |
p. 180-
1 p.
|
artikel
|
| 20 |
The facial paralyses of Jules Verne
|
Perciaccante, Antonio
|
|
2017
|
16 |
3 |
p. 186-
1 p.
|
artikel
|
| 21 |
The Human Brain Project: adjusting the flagship's course
|
The Lancet Neurology,
|
|
2017
|
16 |
3 |
p. 171-
1 p.
|
artikel
|
| 22 |
Understanding brain development: a major step
|
Evans, Alan C
|
|
2017
|
16 |
3 |
p. 178-179
2 p.
|
artikel
|
| 23 |
Understanding the brain through large, multidisciplinary research initiatives
|
Quaglio, Gianluca
|
|
2017
|
16 |
3 |
p. 183-184
2 p.
|
artikel
|
| 24 |
Unrestful art
|
Martin, Colin
|
|
2017
|
16 |
3 |
p. 187-
1 p.
|
artikel
|
| 25 |
Wide implications of a trial on pitolisant for cataplexy
|
Baumann, Christian R
|
|
2017
|
16 |
3 |
p. 173-174
2 p.
|
artikel
|
Tijdschrift beschrijving